Ovarian Cancer Treatment With a Liposome Formulated mRNA Vaccine in Combination With (Neo-)Adjuvant Chemotherapy
Clinical trial NCT04163094 · TERMINATED
Trial details
- NCT number
- NCT04163094
- Sponsor
- University Medical Center Groningen
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-25
- Primary completion
- 2023-06-26
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.